INVESTOR RELATIONS

Company Profile


Apyx® Medical Corporation is a surgical aesthetics company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® and the AYON Body Contouring SystemTM in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The AYON Body Contouring System is an FDA-cleared, groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, electrosurgical capabilities and Renuvion for tissue contraction, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.

Address

Apyx Medical Corporation
5115 Ulmerton Road • Clearwater, FL 33760-4004 • USA
Ph +1 727 384 2323

Management Team

Charles D. Goodwin, President and Chief Executive Officer | Bio
Matt Hill, Chief Financial Officer | Bio
Moshie Citronowicz, Senior Vice President | Bio
Shawn Roman, Chief Operating Officer | Bio

Board of Directors

Stavros Vizirgianakis, Executive Chairman of the Board of Directors | Bio
Charles D. Goodwin, Chief Executive Officer & Director | Bio
Lawrence J. Waldman, CPA, Director | Bio
Minnie Baylow-Henry, Director, Chair of Regulatory & Compliance Committee | Bio
Wendy Levine, Director | Bio

Company Profile


Apyx® Medical Corporation is a surgical aesthetics company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® and the AYON Body Contouring SystemTM in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The AYON Body Contouring System is an FDA-cleared, groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, electrosurgical capabilities and Renuvion for tissue contraction, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.

Press Releases

  • 2026 Shareholder News,PRESS RELEASE

    Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

  • 2026 Shareholder News,Investor Events,PRESS RELEASE

    Apyx Medical Corporation to Participate in Upcoming Investor Conferences

  • 2026 Shareholder News,J-Plasma,PRESS RELEASE

    Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Presentations

Company Investor
Presentation

Investor Contact

Investor Inquiries

investor.relations@apyxmedical.com

Transfer Agent Contact

Broadridge
Ph +1 877 830 4936 or +1 720 378 5591
shareholder@broadridge.com

Press & Other Related Inquiries

press.inquiries@apyxmedical.com

Presentations

Investor Contact

Upcoming Events

Management will host a conference call to discuss the results of the quarter, followed by a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 20167. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical Earnings Webcast.

UBS Global Healthcare Conference

November 9 @ 10:15 am - 5:00 pm

Management will participate in a fireside chat at and will host one-on-one meetings with investors. The fireside chat will be accessible via live webcast here.

Miami, FL

Management will present at and will host one-on-one meetings with investors. The formal presentation will be accessible via live webcast here.

New York, NY

Past Events

Miami, FL

Charlie Goodwin, CEO, and Matt Hill, CFO, participate in a fireside chat and one-on-one meetings with investors throughout the day. The fireside chat replay is available here.

Boston, MA

Charlie Goodwin, CEO, and Matt Hill, CFO, participate in a fireside chat and one-on-one meetings with investors throughout the day. The fireside chat replay is available here.

Management will host a conference call to discuss the results of the quarter, followed by a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 20167. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call […]

UBS Global Healthcare Conference

November 9 @ 10:15 am - 5:00 pm

Management will participate in a fireside chat at and will host one-on-one meetings with investors. The fireside chat will be accessible via live webcast here.

Miami, FL

Management will present at and will host one-on-one meetings with investors. The formal presentation will be accessible via live webcast here.

New York, NY